Evidence map›Paper›PMID 36252567›Full record

ArticleTobacco control2022

Risk and safety profile of electronic nicotine delivery systems (ENDS): an umbrella review to inform ENDS health communication strategies.

Taghrid Asfar, Rime Jebai, Wei Li, Olusanya Joshua Oluwole, Tarana Ferdous, Prem Gautam, Michael Schmidt, Seth M Noar, Eric N Lindblom, Thomas Eissenberg and 3 more

Abstract read
In one paragraph

Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Sharing Antivaping Social Media Messages.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2025
    Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Development of Survey Measures of Uncontrolled Vaping and Vaping Restraint.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Nicotine and Toxicant Exposure among Individuals using both Combustible Cigarettes and E-cigarettes Based on Level of Product Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  14. The Future of e-Cigarette Health Warnings.JAMA internal medicine · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Taghrid AsfarDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA tasfar@med.miami.edu.ORCID http://orcid.org/0000-0003-1133-9723
Rime JebaiRobert Stempel College of Public Health and Social Work, Department of Epidemiology, Florida International University, Miami, FL, USA.
Wei LiDepartment of Psychiatry, Yale School of Medicine, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-7530-3485
Olusanya Joshua OluwoleDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Tarana FerdousRobert Stempel College of Public Health and Social Work, Department of Epidemiology, Florida International University, Miami, FL, USA.
Prem GautamRobert Stempel College of Public Health and Social Work, Department of Epidemiology, Florida International University, Miami, FL, USA.ORCID http://orcid.org/0000-0003-0472-3807
Michael SchmidtDepartment of Art, The University of Memphis, Memphis, TN, USA.
Seth M NoarHussman School of Journalism and Media, University of North Carolina System, Chapel Hill, NC, USA.
Eric N LindblomO'Neill Institute for National & Global Health Law, Georgetown University Law Center, Washington, DC, USA.ORCID http://orcid.org/0000-0003-0627-0987
Thomas EissenbergPsychology and Institute for Drug/Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA.ORCID http://orcid.org/0000-0002-8277-5437
Zoran BursacBiostatistics, Florida International University, Robert Stempel College of Public Health and Social Work, Miami, FL, USA.
Donna ValloneSchroeder Institute, Truth Initiative, Washington, DC, USA.ORCID http://orcid.org/0000-0001-9841-9333
Wasim MaziakEpidemiology, Florida International University, Robert Stempel College of Public Health and Social Work, Miami, FL, USA.ORCID http://orcid.org/0000-0001-6126-8420

Funding

Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3U54DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRELAND, ALISON · 2018 to 2022
$20.8M
Developing and testing health warning labels on the ENDS deviceR01DA051836 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI ASFAR, TAGHRID, MAZIAK, WASIM · 2021 to 2025
$2.4M
NIDA NIH HHS R01 DA051836NIDA NIH HHS U54 DA036105
6 · The paper itself

Abstract

objectivesThis umbrella review aims to summarise the evidence about electronic nicotine delivery systems' (ENDS) risk and safety health profile to inform ENDS health communication strategies. DATA SOURCES AND STUDY SELECTION: Six databases were searched for systematic reviews presenting evidence on ENDS-related health effects. Ninety reviews divided into five categories were included: toxicity=20, health effects=40, role in smoking cessation=24, role in transition to combustible cigarettes (CCs)=13 and industry marketing claims=4. DATA EXTRACTION: Findings were synthesised in narrative summaries. Meta-analyses were conducted by study type when appropriate. Quality assessment was conducted using the Measurement Tool to Assess Systematic Reviews. The Institute of Medicine's Levels of Evidence Framework was used to classify the evidence into high-level, moderate, limited-suggestive and limited-not-conclusive. DATA SYNTHESIS: We found high-level evidence that ENDS exposes users to toxic substances; increases the risk of respiratory disease; leads to nicotine dependence; causes serious injuries due to explosion or poisoning; increases smoking cessation in clinical trials but not in observational studies; increases CC initiation; and exposure to ENDS marketing increases its use/intention to use. Evidence was moderate for ENDS association with mental health and substance use, limited-suggestive for cardiovascular, and limited-not-conclusive for cancer, ear, ocular and oral diseases, and pregnancy outcomes.

conclusionsAs evidence is accumulating, ENDS communication can focus on high-level evidence on ENDS association with toxicity, nicotine addiction, respiratory disease, ENDS-specific harm (explosion, poisoning) and anti-ENDS industry sentiment. Direct comparison between the harm of CCs and ENDS should be avoided. PROSPERO REGISTRATION NUMBER: CRD42021241630.

Indexed as

Advertising and PromotionElectronic nicotine delivery devicesHuman rightsPublic policySmoking Caused Disease

Identifiers

PMID36252567
PMCPMC10043882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.